Manitoba Renal Program Journal Club

  1. KHM Staff Portal
  2. Education Opportunities for Staff
  3. Manitoba Renal Program Journal Club

Manitoba Renal Program Journal Club

MRP Journal Club offers learning opportunities for MRP nursing and allied health staff.

The Dial-Mag Study Update

April 10, 2025
2 p.m.

Presented virtually via Teams.

Session video is available below in the Past Journal Clubs section.

Certificates

If you would like a certificate, please complete our survey, and then send an email to mdelosreyes2@sharedhealthmb.ca.

The journal club meets periodically to learn about and discuss relevant topics related to ongoing and upcoming issues in nephrology nursing. For more information contact the MRP Education Office at 204-787-3317 or kidneyhealth@sharedhealthmb.ca

Past Journal Clubs

Dialysate Magnesium Trial: Outcomes of a higher vs. lower hemodialysate magnesium concentration: A pragmatic cluster randomized clinical trial in hemodialysis centres (Post Implementation Follow Up)

Video recorded Tuesday, May 17, 2022.

Presented virtually via Teams by Dr. Clara Bohm, BScH, MD, MPH, FRCPC, Associate Professor University of Manitoba, MRP Nephrologist.
Every hemodialysis facility in Manitoba will be participating in the Dial-Mag Study. In order to hear the study update, watch this video. Video presentation recorded April 11, 2022.
Video presentation recorded March 15, 2022.
Every hemodialysis facility in Manitoba will be participating in the Dial-Mag Study. In order to hear what the project is, what is involved, the parameters being collected and the role the hemodialysis facilities will be playing, watch this video. Video presentation recorded March 11, 2022.

Click here to see the Continuing Education Session Evaluation.

Click here to see the trial poster.
Introducing the Chronic Disease Innovation Center (CDIC), which is actively doing research projects in nephrology. Robust research projects require intensive attention to details and data and/or information collection. An example of an ongoing research project that has met all the requirements for approval and is being conducted in the nephrology population currently is: A pragmatic randomized controlled trial of a CKD specific telemonitoring platform to minimize adverse outcomes in high risk CKD patients. Dr. Rigatto will explain the project, the current progress of the project and share the possible impact of the results.